Equity Overview
Price & Market Data
Price: $0.044
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $30,876,144
Daily Volume: 0
Performance Metrics
1 Week: -2.22%
1 Month: -2.22%
3 Months: 266.7%
6 Months: -12.00%
1 Year: 83.33%
YTD: -2.44%
About MedMira Inc. (MMIRF)
Essential overview of MedMira Inc. (MMIRF). Price: 0.044, daily change: $0.00 / 0.00%. Market cap: 30,876,144. YTD and 6-month performance insights.
Details
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.